Abstract Stem cell–based therapies offer potential for repairing large skeletal defects, yet persistent inflammation limits their efficacy. Here, we identify macrophage–derived IL-18 as an immune switch that impairs skeletal regeneration by disrupting immune–mesenchymal cell interactions. IL-18 is elevated in male mouse non-healing models and human bone nonunion samples, supporting its translational relevance.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jiahan
Contact Jiahan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack